2011-09-18T21:46:12Z http://portal.pharmaconnections.com/forum/categories/seeking-investment/listForCategory?feed=yes&xn_auth=no SeekingInvestment-PharmaConnectionshttp://feedburner.google.comSeekingInvestment-PharmaConnectionsWorldwidehttp://feedburner.google.com tag:portal.pharmaconnections.com,2011-06-19:2831115:Topic:36015 2011-06-19T11:48:54.203Z Pharma Connections Marketing http://portal.pharmaconnections.com/profile/PharmaConnectionsMarketing

<p><a target="_blank" href="http://igylifesciences.com/"><img class="align-full" src="http://api.ning.com:80/files/D0*T4hALEF6HcRt7qkzAKtC33yZm4VGSU7oGVmWcmsWcSsTrzJTEZDyzHuvimr3LivgmWha*2m*SddxVAEVRpDipMfKtNd6c/IgY_Logo.jpg" width="200"/></a></p> <p> </p> <p>Please send an inquiry to <a href="mailto:sales@pharmaconnections.com" target="_tblank">sales@pharmaconnections.com</a> for more information.</p> <p> </p> <p><b>Company :</b> Immune Technologies &amp; Life Sciences Inc.</p> <p><b>Seeking…</b></p>

<p><a target="_blank" href="http://igylifesciences.com/"><img class="align-full" src="http://api.ning.com:80/files/D0*T4hALEF6HcRt7qkzAKtC33yZm4VGSU7oGVmWcmsWcSsTrzJTEZDyzHuvimr3LivgmWha*2m*SddxVAEVRpDipMfKtNd6c/IgY_Logo.jpg" width="200"/></a></p> <p> </p> <p>Please send an inquiry to <a href="mailto:sales@pharmaconnections.com" target="_tblank">sales@pharmaconnections.com</a> for more information.</p> <p> </p> <p><b>Company :</b> Immune Technologies &amp; Life Sciences Inc.</p> <p><b>Seeking :</b> Investment &amp; Letters of Intent to Distribute/License</p> <p><b>Area of Focus :</b> Cosmateutical, Nutraceutical, Pharmaceutical</p> <p> </p> <p><b>Non Confidential Executive Summary Download :</b> <a href="http://www.pharmaconnections.com/Investment_Opps/IgY/IGY-April_2011.pdf" target="_tblank">Click Here</a></p> <p><b>Non Confidential Investor Fact Sheet Download :</b> <a href="http://www.pharmaconnections.com/Investment_Opps/IgY/IGYTECH_Investor_Fact_Sheet.pdf" target="_tblank">Click Here</a></p> <p><b>Non Disclosure Agreement Download :</b> <a href="http://www.pharmaconnections.com/Investment_Opps/IgY/Confidentiality_Agreement_IGY.docx" target="_tblank">Click Here</a></p> <p><b>Confidential Document Directory :</b> <a href="http://www.pharmaconnections.com/Investment_Opps/IgY/Confidential">Click Here (Password Required)</a></p> <p> </p> <p><b>Website :</b> <a href="http://www.igylifesciences.com/" target="_tblank">www.igylifesciences.com</a></p> <p> </p> <p><b>About Immune Technologies &amp; Life Sciences Inc.:</b></p> <p>Our proprietary technology and processes makes it possible to create health products to strengthen and supplement your natural immune system against certain types of bacterial, viral and autoimmune ailments.</p> <p> </p> <p>IGY Immune Technologies and Life Sciences specializes in the extraction of polyclonal antibodies, a type of antibody that are derived from chicken eggs for use as nutraceuticals and pharmaceuticals for human and animal consumption.</p> <p> </p> <p>Immunoglobulins are powerful antibodies produced in healthy humans and other animals to fight infections and prevent disease. Egg yolks contain immunoglobulin IgY, the functional equivalent of immunoglobulin IgG which makes up 75% of the immunoglobulin found in healthy human plasma.</p> <p> </p> <p><b>Highlights :</b></p> <ul> <li>Currently looking to sign Letter's of Intent with nutraceutical distribution partners to commercially launch several products in Healthcare space</li> <li>Interested in licensing/partnering discussions surrounding the technology in the area of pandemic vaccines, and infectious diseases</li> <li>Seeking equity investment partnerships ..</li> </ul> <p> </p> <p>Please send an inquiry to <a href="mailto:sales@pharmaconnections.com" target="_tblank">sales@pharmaconnections.com</a> for more information.</p> <img src="http://feeds.feedburner.com/~r/SeekingInvestment-PharmaConnections/~4/ZOV6KfjPTTQ" height="1" width="1"/> <p><a href="http://feedads.g.doubleclick.net/~a/uzOinpgT5aGazm7owfomWvzTSLU/0/da"><img src="http://feedads.g.doubleclick.net/~a/uzOinpgT5aGazm7owfomWvzTSLU/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/uzOinpgT5aGazm7owfomWvzTSLU/1/da"><img src="http://feedads.g.doubleclick.net/~a/uzOinpgT5aGazm7owfomWvzTSLU/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/SeekingInvestment-PharmaConnectionsWorldwide/~4/mjYVsIlrDq0" height="1" width="1"/> http://portal.pharmaconnections.com/xn/detail/2831115:Topic:36015http://feedproxy.google.com/~r/SeekingInvestment-PharmaConnections/~3/ZOV6KfjPTTQ/2831115:Topic:36015 tag:portal.pharmaconnections.com,2011-04-27:2831115:Topic:33895 2011-04-27T13:21:20.752Z Pharma Connections Marketing http://portal.pharmaconnections.com/profile/PharmaConnectionsMarketing

<p><span class="font-size-3">Please send an inquiry to <a href="mailto:sales@pharmaconnections.com" target="_tblank">sales@pharmaconnections.com</a> for more information on this opportunity.</span></p> <table width="525" border="0.1"> <tbody><tr><td width="519"><p class="style35 style1"><span class="font-size-4">Investment Opportunity :</span></p> <p class="style35 style1"><span class="font-size-4"><br/></span></p> <p class="style35" align="center">…</p> </td> </tr> </tbody> </table>

<p><span class="font-size-3">Please send an inquiry to <a href="mailto:sales@pharmaconnections.com" target="_tblank">sales@pharmaconnections.com</a> for more information on this opportunity.</span></p> <table width="525" border="0.1"> <tbody><tr><td width="519"><p class="style35 style1"><span class="font-size-4">Investment Opportunity :</span></p> <p class="style35 style1"><span class="font-size-4"><br/></span></p> <p class="style35" align="center"><img src="http://www.pharmaconnections.com/pcw/images/companylogo/betacatlogo.jpg" alt="BetaCat" longdesc="http://www.pharmaconnections.com/pcw/images/companylogo/Nicobloc1.jpg" width="175" border="0" height="75"/></p> </td> </tr> <tr><td class="style36"><span class="style36 style4"><strong>Company :</strong> Beta Cat Pharmaceuticals</span></td> </tr> <tr><td class="style36"><p class="style36 style4"><strong>Seeking :</strong> Private Equity /Venture Capital Investment</p> </td> </tr> <tr><td class="style36"><p class="style36 style4"><strong>Area of Focus :</strong> WNT/Beta Catenin Inhibition - BC2059 (Oncology)</p> </td> </tr> <tr><td class="style36"><p><span class="style36 style4"><strong>Non Confidential Executive Summary Download :</strong> <a href="http://www.pharmaconnections.com/Investment_Opps/BetaCat/Beta_Cat_BC2059_Executive_Summary.pdf" target="_tblank" class="style35">Click Here</a></span></p> <p><strong>Website :</strong> <a href="http://www.pharmaconnections.com/pcw/Beta_Cat.html" target="_self">Link to Pharma Connections</a></p> <p> </p> <table width="525" border="0.1"> <tbody><tr><td><p class="style4 style35"><strong>About Beta Cat:</strong></p> <p>β Cat Pharmaceuticals, LLC (“β Cat” or the “Company”) is seeking financial partners for the development of and future sale to a pharmaceutical partner of compounds from its WNT/betacatenin inhibitor program, which it is in the process of acquiring from the innovator company.The innovator company was a casualty of the recent financial meltdown in the USA, and lost its financing after its lead program failed in the clinic and the failure of financial companies in the<br/> USA made refinancing an impossibility. It was acquired, and the acquiring company is not in oncology and is liquidating the assets of the company. The lead compound, which on acquisition by β Cat, will become BC2059, is in late stage preclinical development and, assuming a positive outcome from pending IND-enabling GLP toxicity studies, should be ready for human clinical trials within a year. Preclinical data suggests that BC2059 and related compounds, and other<br/> distinct compound families discovered in this program, are potent and specific inhibitors of WNT pathway function</p> </td> </tr> <tr><td><p class="style4"><strong>Highlights :</strong></p> <p>• BC2059 is a potent and specific small molecule inhibitor of beta-catenin protein function and WNT pathway activity.<br/> • Causes specific degradation of beta catenin protein<br/> • Has little or no activity in non-cancerous cells<br/> • Depletes pharmacodynamic (PD) markers upon short term treatment of tumor bearing mice<br/> • Significantly reduces tumor growth in mouse xenograft models<br/> • Preclinical pharmacological properties have been optimized and GMP drug<br/> substance has been produced</p> <p>• Good pharmacokinetic properties and potential therapeutic window</p> </td> </tr> </tbody> </table> <p>Please send an inquiry to <a href="mailto:sales@pharmaconnections.com" target="_tblank">sales@pharmaconnections.com</a> for more information</p> </td> </tr> </tbody> </table> <img src="http://feeds.feedburner.com/~r/SeekingInvestment-PharmaConnections/~4/Zm7qTUxfrvY" height="1" width="1"/> <p><a href="http://feedads.g.doubleclick.net/~a/WfFMCG6abdfsriCQhpahTn6JPN8/0/da"><img src="http://feedads.g.doubleclick.net/~a/WfFMCG6abdfsriCQhpahTn6JPN8/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/WfFMCG6abdfsriCQhpahTn6JPN8/1/da"><img src="http://feedads.g.doubleclick.net/~a/WfFMCG6abdfsriCQhpahTn6JPN8/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/SeekingInvestment-PharmaConnectionsWorldwide/~4/gxt_9sp6E0Q" height="1" width="1"/> http://portal.pharmaconnections.com/xn/detail/2831115:Topic:33895http://feedproxy.google.com/~r/SeekingInvestment-PharmaConnections/~3/Zm7qTUxfrvY/2831115:Topic:33895 tag:portal.pharmaconnections.com,2011-03-12:2831115:Topic:24852 2011-03-12T00:33:19.535Z Pharma Connections Admin http://portal.pharmaconnections.com/profile/Admin

<br/> <p><a href="http://feeds.feedburner.com/SeekingInvestment-PharmaConnections"><img class="align-right" src="http://feeds.feedburner.com/~fc/SeekingInvestment-PharmaConnections?bg=043455&amp;fg=FFFFFF&amp;anim=1" style="border: 0;" height="26" width="88"/></a></p> <br/> <br/> <br/> <span class="font-size-6" style="color: #333300;"><a href="http://feedburner.google.com/fb/a/mailverify?uri=SeekingInvestment-PharmaConnectionsWorldwide&amp;loc=en_US">Subscribe to Seeking Investment - by…</a></span>

<br/> <p><a href="http://feeds.feedburner.com/SeekingInvestment-PharmaConnections"><img class="align-right" src="http://feeds.feedburner.com/~fc/SeekingInvestment-PharmaConnections?bg=043455&amp;fg=FFFFFF&amp;anim=1" style="border: 0;" height="26" width="88"/></a></p> <br/> <br/> <br/> <span class="font-size-6" style="color: #333300;"><a href="http://feedburner.google.com/fb/a/mailverify?uri=SeekingInvestment-PharmaConnectionsWorldwide&amp;loc=en_US">Subscribe to Seeking Investment - by Email</a></span> <img src="http://feeds.feedburner.com/~r/SeekingInvestment-PharmaConnections/~4/vYRuO7RrIfE" height="1" width="1"/> <p><a href="http://feedads.g.doubleclick.net/~a/zW14bNjoDYTcebaEdbK6MM_MwAo/0/da"><img src="http://feedads.g.doubleclick.net/~a/zW14bNjoDYTcebaEdbK6MM_MwAo/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/zW14bNjoDYTcebaEdbK6MM_MwAo/1/da"><img src="http://feedads.g.doubleclick.net/~a/zW14bNjoDYTcebaEdbK6MM_MwAo/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/SeekingInvestment-PharmaConnectionsWorldwide/~4/9I9ii59gvaE" height="1" width="1"/> http://portal.pharmaconnections.com/xn/detail/2831115:Topic:24852http://feedproxy.google.com/~r/SeekingInvestment-PharmaConnections/~3/vYRuO7RrIfE/2831115:Topic:24852